Ovarian Cancer Trial, Recruiting NCT04473833 Sponsor: John R van Nagell Condition: Ovarian Cancer
Back to Ovarian Cancer

Ovarian Cancer Trial, Recruiting

NCT04473833
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Women over the age of 50 years.
  • Women over the age of 24 years who have a documented family history of ovarian cancer.
  • Women over the age of 24 years who have a personal history of breast cancer.
  • People with a general health status rated as fully active, restricted in strenuous activity, or capable of self-care but unable to work (confirm with trial site for exact rating details).
  • Women who have previously had a hysterectomy (surgical removal of the uterus) may still be eligible, as long as at least one ovary remains and other entry requirements are met.
  • People who are able to understand the study and are willing to sign a written consent form agreeing to take part.

Who may not be able to join:

  • Women who have been referred because of pelvic symptoms, a known pelvic mass (growth or lump in the pelvic area), or a history of radiation treatment.
  • People for whom a transvaginal ultrasound (an internal scan using a small probe) cannot be safely performed, due to reasons such as vaginal size, vaginal infection, lack of bladder or bowel control, or inability to get into the required position.
  • People who are currently in prison.
  • Women who are pregnant.
  • Women who have previously been diagnosed with ovarian cancer.
  • People who have any factor that prevents them from understanding the study procedures or from completing the consent form and providing the personal information required for the study.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: John R Van Nagell, MD, University of Kentucky

Phone: 859-323-3830

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
John R van Nagell
Registry
ClinicalTrials.gov
Start date
19 December 1988
Est. completion
31 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

False-positive (FP) percentage

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov